期刊文献+

辐射诱导表达载体pshuttle-Egr1-shTRAIL对肝癌SMMC7721细胞生长的抑制作用

Inhibitory effects of recombinant plasmid pshuttle-Egr1-shTRAIL transfection in combination with X-irradiation on growth of liver cancer cells SMMC7721
暂未订购
导出
摘要 目的:研究携带可溶性人肿瘤坏死因子相关凋亡诱导配体(shTRAIL)基因的辐射诱导表达载体pshuttle-Egr1-shTRAIL在人肝癌细胞株中的表达及其促凋亡作用。方法:体外通过脂质体转染SMMC7721细胞。转染细胞分别接受0(假照组)、2、5和10Gy X线照射,ELISA法检测sTRAIL的表达;细胞分为正常SMMC7721组,分别接受0(假照组)、2和5Gy X线照射的转染空质粒pshuttle-Egr1组及转染重组质粒pshutlle-Eyr1-shTRAIL组,采用AnnexinV-FITC凋亡检测试剂盒检测细胞凋亡率;分别取SMMC772细胞、转染STRAIL细胞、转染空载体及照射组细胞,采用克隆形成实验检测细胞存活率。结果:不同剂量X射线照射SMMC7721-shTRAIL细胞上清中可溶性TRAIL表达量明显高于假照组(P<0.001);与假照组比较,照射转染后SMMC7721细胞的凋亡细胞百分数明显增加(P<0.05或P<0.001),细胞存活率明显下降(P<0.05或P<0.001)。结论:pshuttle-Egr1-shTRAIL载体联合放射治疗能够显著抑制肝癌细胞SMMC7721细胞的生长,并促进其凋亡。 Objective To investigate the effects of recombinant plasmid pshuttle-Egr1-shTRAIL stable transfection in combination with X-ray irradiation on the TRAIL protein expression and the apoptosis in human SMMC7721 hepatoma cells.Methods The pshuttle-Egr1-shTRAIL packaged with liposome was stably transfected into SMMC7721 cells in vitro.The shTRAIL protein expressions were measured with ELISA assay,Annexin V-FITC kit was adopted to measure the apoptosis of pshuttle-Egr1-shTRAIL cells,and the changes in survival rate of SMMC7721 cells were measured with cell cloning assay.Results The TRAIL protein expressions in pshuttle-Egr1-shTRAIL plus different doses of irradiation groups were significantly increased compared with 0 Gy group(P< 0.001).The percentage of apoptotic cells was significantly higher than that in 0 Gy group(P<0.05 or P<0.001),and the survival rate of SMMC7721 cells was decreased significantly(P<0.05 or P<0.001).Conclusion The pshuttle-Egr1-shTRAIL stable transfection in combination with irradiation can significantly induce the apoptosis of SMMC7721 tumor cells and inhibit the cell proliferation.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2011年第6期981-984,共4页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(30570546)
关键词 肿瘤坏死因子相关凋亡诱导配体 基因克隆 肝肿瘤 辐射 早期生长反应1 pshuttle-Egr1-shTRAIL gene clone human hepatoma SMMC7721 irradiation gene therapy
  • 相关文献

参考文献15

  • 1江亚南,马俊芬,黄幼田,李沛,李芳芳,杨浩,董子明.顺铂对TRAIL诱导EC1细胞凋亡的增敏效应[J].郑州大学学报(医学版),2011,46(3):346-348. 被引量:2
  • 2朴春姬,田梅,刘林林,杨巍,李修义1.辐射诱导表达载体pEgr-hTRAIL的构建及其对肿瘤细胞的体外诱导凋亡作用[J].吉林大学学报(医学版),2005,31(2):169-172. 被引量:7
  • 3Sammy A. Baierlein,Luitpold Distel,Renate Sieber,Christian Weiss,Claus R?del,Rolf Sauer,Franz R?del PhD.Combined Effect of Tumor Necrosis Factor-alpha and Ionizing Radiation on the Induction of Apoptosis in 5637 Bladder Carcinoma Cells[J]. Strahlentherapie und Onkologie . 2006 (8)
  • 4H. Wajant,K. Pfizenmaier,P. Scheurich.TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy[J]. APOPTOSIS . 2002 (5)
  • 5Hu Y,Ouyang W,Wu F,et al.Enhanced radiosensitivity ofSW480 cells via TRAIL up-regulation mediated by Egr-1promoter. Oncology Reports . 2009
  • 6Ma H,Liu YX,Liu SLet al.Recombinant adeno-associated virus-mediated TRAIL gene therapy suppresses liver metastatic tumors. International Journal of Cancer . 2005
  • 7Weichselbaum RR,Hallahan DE,Beckett MA,et al.Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Research . 1994
  • 8Wiley S R,Schooley K,Smolak P J,et al.Identification and characterization of a new member of the TNF family. Immunity . 1995
  • 9Pitti RM,Marster SA,Ruppert S,et al.Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. Journal of Biological Chemistry . 1996
  • 10Di Pietro R,Secchiero P,Rana R,et al.Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective up-regulation of TRAIL-R1. Blood . 2001

二级参考文献16

  • 1徐玉生,许建中,苗金红,杨迪生.顺铂、TRAIL单独或联合应用对横纹肌肉瘤细胞生长的影响[J].郑州大学学报(医学版),2006,41(4):691-693. 被引量:3
  • 2Jin H, Yang R, Fong S, et al. Apo2 ligand/tumnr necro- sis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit nrthotopic lung tumor growth and improve survival[J]. Cancer Res, 2004, 64(14) :4900.
  • 3Ashkenazi A, Pal RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand[ J ]. J Clin In- vest, 1999, 104(2):155.
  • 4Vignati S, Codegoni A, Polato F, et al. Trail activity in human ovarian eancer ceils: potentiation of the action of cytotoxic drugs[J]. Eur J Cancer, 2002,38( 1 ) :177.
  • 5Pan G, O ' Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIl, [ J ]. Science, 1997,276 (5309) :111.
  • 6Wiezorek J, Holland P, Graves J. Death receptor agonists as a targeted therapy for cancer [ J ]. Clin Cancer Res, 2010, 16(6) :1701.
  • 7Mahmood Z, Shukla Y. Death receptors: targets lbr cancer therapy[J]. Exp Cell Res, 2010, 316(6) :887.
  • 8Kermpler A, Deckbar D, Jeggop A, et al. An imperfect G2M eheckpoint contributes to chromosome instability fol- lowing irradiation of S and G2 phase cells [ J ]. Cell Cycle, 2007,6(14) :1682.
  • 9Scott SD, Marples B, Hendry JH, et al. A radiation-controlled molecular switch for use in gene therapy of cancer [J]. Gene Ther, 2000, 7: 1121-1125.
  • 10Wiley SR, Schooley K, Cmolak PJ, et al. Identification and characterization of a new member of the TNF family that induce apoptosis [J]. Immunity, 1995, 3 (6): 673-682.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部